← back to search

Thalia Erbes

University of Freiburg · DE
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Breast Cancer Treatment Studies, Extracellular vesicles in disease, and Cancer-related molecular mechanisms research.
h-index
22
citations
1,409
works
83
NIH funding
primary concept
email

Recent publications

Serum Proteome Profiling Identifies N-Cadherin and C-Met as Early Marker Candidates of Therapeutic Response to Neoadjuvant Chemotherapy in Breast Cancer
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: middledoi
Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
Frontiers in Oncology 2023cited by 3position: middledoi
Highly Sensitive Nanomagnetic Quantification of Extracellular Vesicles by Immunochromatographic Strips: A Tool for Liquid Biopsy
Nanomaterials 2022cited by 24position: middledoi
Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer
Breast Cancer Research 2022cited by 17position: middledoi
Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis
BMC Cancer 2022cited by 8position: middledoi
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis
Cancers 2021cited by 54position: middledoi
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
Strahlentherapie und Onkologie 2021cited by 13position: middledoi
High Numbers and Densities of PD1+ T-Follicular Helper Cells in Triple-Negative Breast Cancer Draining Lymph Nodes Are Associated with Lower Survival
International Journal of Molecular Sciences 2020cited by 4position: middledoi
Tspan8 is expressed in breast cancer and regulates E‐cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles
The Journal of Pathology 2019cited by 52position: middledoi
Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype
Scientific Reports 2018cited by 14position: middledoi
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist <sup>68</sup>Ga-RM2 And PET
Theranostics 2016cited by 119position: middledoi
BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis
Clinical Breast Cancer 2016cited by 31position: firstdoi
Alterations of the exo- and endometabolite profiles in breast cancer cell lines: A mass spectrometry-based metabolomics approach
Analytica Chimica Acta 2016cited by 30position: middledoi
Hyperthermia-driven aberrations of secreted microRNAs in breast cancer <i>in vitro</i>
International Journal of Hyperthermia 2016cited by 6position: firstdoi
Implementation of a Molecular Tumor Board in Clinical Decision Making at the Medical Center University of Freiburg
Blood 2016cited by 0position: middledoi
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
BMC Cancer 2015cited by 145position: firstdoi
HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer
BMC Cancer 2015cited by 31position: middledoi
Exometabolom analysis of breast cancer cell lines: Metabolic signature
Scientific Reports 2015cited by 29position: middledoi
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
Oncotarget 2015cited by 6position: middledoi
Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection
BMC Cancer 2014cited by 39position: firstdoi
Endoxifen and fulvestrant regulate gene expression of estrogen receptor alpha and its co-activators DEADbox5 and 17
Geburtshilfe und Frauenheilkunde 2014cited by 0position: middledoi
Hypoxia‐dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression
Molecular Carcinogenesis 2013cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elmar Stickeler · University Hospital Cologne11 papers (2013–2016)Marc Hirschfeld · Spanish Head & Neck Cancer Cooperative Group10 papers (2013–2016)Sebastian Mayer · Cornell University7 papers (2013–2016)Peter Bronsert · University of Freiburg5 papers (2015–2022) · 5 papers (2014–2016)Martin Werner · University of Freiburg4 papers (2016–2022)Markus Jäger · Ludwig-Maximilians-Universität München4 papers (2015–2024) · 3 papers (2014–2016)Anca‐Ligia Grosu · German Marine Research Consortium3 papers (2021–2023)David Krug · University Hospital Heidelberg3 papers (2021–2023)Oliver Schilling · University of Lübeck3 papers (2018–2024) · 3 papers (2015–2016) · 3 papers (2015–2016) · 3 papers (2013–2015) · 3 papers (2021–2023)Philipp T. Meyer · University Medical Center Freiburg2 papers (2014–2016)Tilman Brummer · University of Freiburg2 papers (2015–2016)Raluca Stoian · University of Freiburg2 papers (2021–2023) · 2 papers (2015–2024) · 2 papers (2014–2015)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →